162 related articles for article (PubMed ID: 3007164)
1. In vitro effect of fansimef on human neutrophil and monocyte function.
Kharazmi A; Nielsen H
Eur J Clin Pharmacol; 1986; 29(5):587-90. PubMed ID: 3007164
[TBL] [Abstract][Full Text] [Related]
2. Mefloquine and sulfadoxine/pyrimethamine resistant Plasmodium falciparum.
Arnold K
Lancet; 1986 Jan; 1(8473):154. PubMed ID: 2867368
[No Abstract] [Full Text] [Related]
3. Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria.
Kollaritsch H; Stemberger H; Mailer H; Kremsner P; Kollaritsch R; Leimer R; Wiedermann G
Trans R Soc Trop Med Hyg; 1988; 82(4):524-9. PubMed ID: 2908258
[TBL] [Abstract][Full Text] [Related]
4. Determination of pyrimethamine in human plasma after administration of fansidar of fansidar-mefloquine by means of high-performance liquid chromatography with fluorescence detection.
Timm U; Weidekamm E
J Chromatogr; 1982 Jun; 230(1):107-14. PubMed ID: 6980889
[TBL] [Abstract][Full Text] [Related]
5. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
Ekue JM; Phiri DE; Sheth UK; Mukunyandela M
Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440
[TBL] [Abstract][Full Text] [Related]
6. Antimalarial drugs and human neutrophil oxidative metabolism.
Kharazmi A
Trans R Soc Trop Med Hyg; 1986; 80(1):94-7. PubMed ID: 3014691
[TBL] [Abstract][Full Text] [Related]
7. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria.
de Souza JM; Sheth UK; Wernsdorfer WH; Trigg PI; Doberstyn EB
Bull World Health Organ; 1987; 65(3):357-61. PubMed ID: 3311438
[TBL] [Abstract][Full Text] [Related]
8. Mefloquine-pyrimethamine-sulfadoxine combination delays emergence of mefloquine resistant Plasmodium falciparum in continuous culture.
Tan-Ariya P; Brockelman CR; Menabandhu C
Southeast Asian J Trop Med Public Health; 1984 Dec; 15(4):531-5. PubMed ID: 6398918
[TBL] [Abstract][Full Text] [Related]
9. A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects.
de Souza JM; Sheth UK; de Oliveira RM; Gomes AT; Cavalcante EQ
Bull World Health Organ; 1985; 63(3):611-5. PubMed ID: 3899398
[TBL] [Abstract][Full Text] [Related]
10. Double-blind dose finding study of mefloquine-sulfadoxine-pyrimethamine in children with acute falciparum malaria.
Guo XB; Arnold K; Fu LC; Chen PQ; Li GQ
Trans R Soc Trop Med Hyg; 1988; 82(4):538-40. PubMed ID: 3076709
[TBL] [Abstract][Full Text] [Related]
11. RII and RIII type resistance of Plasmodium falciparum to combination of mefloquine and sulfadoxine/pyrimethamine in Indonesia.
Hoffman SL; Rustama D; Dimpudus AJ; Punjabi NH; Campbell JR; Oetomo HS; Marwoto HA; Harun S; Sukri N; Heizmann P
Lancet; 1985 Nov; 2(8463):1039-40. PubMed ID: 2865518
[TBL] [Abstract][Full Text] [Related]
12. Single-dose investigation of possible interactions between the components of the antimalarial combination Fansimef.
Weidekamm E; Schwartz DE; Dubach UC; Weber B
Chemotherapy; 1987; 33(4):259-65. PubMed ID: 3608626
[TBL] [Abstract][Full Text] [Related]
13. Concurrent chloroquine and Fansidar resistance of Plasmodium falciparum: an imported case from Gabon.
Burchard GD; Winkler E
Trop Geogr Med; 1988 Jan; 40(1):68-9. PubMed ID: 3289215
[TBL] [Abstract][Full Text] [Related]
14. Single dose kinetic study of the triple combination mefloquine/sulphadoxine/pyrimethamine (Fansimef) in healthy male volunteers.
Mansor SM; Navaratnam V; Mohamad M; Hussein S; Kumar A; Jamaludin A; Wernsdorfer WH
Br J Clin Pharmacol; 1989 Mar; 27(3):381-6. PubMed ID: 2785812
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of Plasmodium falciparum to mefloquine-sulphadoxine-pyrimethamine (Fansimef) in vivo and to mefloquine alone in vitro in Nigeria.
Salako LA; Aderounmu AF; Laoye JO; Makinde JM; Adio RA
Ann Trop Med Parasitol; 1988 Aug; 82(4):325-30. PubMed ID: 3075441
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.
Fadeke Aderounmu A; Salako LA; Laoye AJ; Modupe Makinde J; Aina Adio R
Afr J Med Med Sci; 1988 Dec; 17(4):195-200. PubMed ID: 2854365
[TBL] [Abstract][Full Text] [Related]
17. The in vitro effect of sulbactam on polymorphonuclear leukocyte function.
Santos JI; Arbo A
Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):147S-152S. PubMed ID: 2556238
[TBL] [Abstract][Full Text] [Related]
18. Effect of cyclosporin A on human neutrophil and monocyte function.
Kharazmi A; Svenson M; Nielsen H; Birgens HS
Scand J Immunol; 1985 Jun; 21(6):585-91. PubMed ID: 4023629
[TBL] [Abstract][Full Text] [Related]
19. Fansimef for prophylaxis of malaria: a double-blind randomized placebo controlled trial.
Bunnag D; Malikul S; Chittamas S; Chindanond D; Harinasuta T; Fernex M; Mittelholzer ML; Kristiansen S; Sturchler D
Southeast Asian J Trop Med Public Health; 1992 Dec; 23(4):777-82. PubMed ID: 1298089
[TBL] [Abstract][Full Text] [Related]
20. Interaction of ceftriaxone with human polymorphonuclear neutrophil function.
Labro MT; Babin-Chevaye C; Pochet I; Hakim J
J Antimicrob Chemother; 1987 Dec; 20(6):849-55. PubMed ID: 2831183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
